StonvexLoading…
StonvexCore line items from GTM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.25B | $1.21B | $1.24B | $1.10B |
Operating Income | $225.70M | $97.40M | $259.50M | $175.80M |
Net Income | $124.20M | $29.10M | $107.30M | $63.20M |
EPS (Diluted) | $0.38 | $0.08 | $0.27 | $0.16 |
Total Assets | $6.44B | $6.47B | $6.87B | $7.14B |
Total Liabilities | $4.93B | $4.77B | $4.75B | $4.86B |
Cash & Equivalents | $175.90M | $139.90M | $447.10M | $418.00M |
Free Cash Flow OCF − CapEx | $389.30M | $304.50M | $408.40M | $388.10M |
Shares Outstanding | 307.29M | 342.03M | 384.83M | 404.08M |